EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Counseling in menopausal women: How to address the benefits and risks of menopause hormone therapy. A FIGO position paper

Andrea R Genazzani, Hema Divakar, Suvarna S Khadilkar, Patrizia Monteleone, Bernadette Evangelisti, Ahmed F Galal, Paola I R Priego, Tommaso Simoncini, Andrea Giannini, Gelila Goba, Chiara Benedetto

International Journal of Gynecology & Obstetrics · 2024-02 · 164 (2) · 516-530

DOI: 10.1002/ijgo.15278 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Gynecology & Obstetrics, online erschienen am 04.01.2024. Verfasst von Andrea R Genazzani und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Obstetrics and Gynecology, Department of Clinical and Experimental Medicine, The University of Pisa, Pisa, Italy. Hauptthemen laut MEDLINE: Estrogen Replacement Therapy, Menopause. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 164 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Menopause marks the end of menstrual cyclicity and, depending on individual vulnerability, has several consequences related to gonadal steroid deprivation, especially if it is premature. Menopause may be more burdensome for some women than for others. Individual factors, such as personal history, socioeconomic status, ethnicity, and current health conditions, affect symptomatology and, thereby, the menopausal experience. In addition, some menopausal symptoms, such as severe hot flashes, sleep disorders, and depression, are markers of future health risks. Counseling is a fundamental part of health care in the peri‐ and postmenopause periods. It must include an assessment of the patient's symptoms, needs, desires, and risk profile to address the benefits and risks of menopausal hormone therapy (MHT) on an individual basis and promote a healthy lifestyle. Indeed, healthcare practitioners can and must protect the health and lives of mid‐life women by increasing awareness of menopausal symptoms and ensuring healthcare options, especially MHT. The type and duration of MHT should be tailored based on the patient's history, menopausal age, physical characteristics, and current health status so that the benefits always outweigh the risks. This FIGO position paper focuses on the benefits and risks of MHT on health domains, target organs, and systems, and on systemic and vaginal MHT regimens, to provide indications that can be used in the clinical practice for menopausal counseling. Moreover, it offers insights into what FIGO considers the mainstay for the healthcare management of women in peri‐ and postmenopause, worldwide.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Estrogen Replacement TherapyMenopauseFemaleHumansPostmenopauseCounselingRisk AssessmentHormone Replacement Therapy

Stichwörter der Autor:innen

bioidentical hormonescounselinghormone therapymenopausal hormone therapy benefitsmenopausal hormone therapy regimensmenopausal hormone therapy risksmenopausal symptomsmenopause

Autor:innen und Institutionen

  • Division of Obstetrics and Gynecology, Department of Clinical and Experimental Medicine, The University of Pisa, Pisa, Italy.
  • Obstetrics and Gynaecology, Divakars Speciality Hospital, Bengaluru, India.
  • FIGO Committee on Well Woman Health Care, London, UK.
  • Department of Obstetrics and Gynecology, Bombay Hospital Institute of Medical Sciences, Mumbai, India.
  • Division of Obstetrics and Gynecology, Azienda USL Toscana Nord Ovest, Pisa, Italy.
  • Department of Obstetrics and Gynecology, Sant'Anna University Hospital, Torino, Italy.

Zitieren

APA

Genazzani, A. R., Divakar, H., Khadilkar, S. S., Monteleone, P., Evangelisti, B., Galal, A. F., Priego, P. I. R., Simoncini, T., Giannini, A., Goba, G., & Benedetto, C. (2024). Counseling in menopausal women: How to address the benefits and risks of menopause hormone therapy. A FIGO position paper. International Journal of Gynecology & Obstetrics, 164(2), 516-530. https://doi.org/10.1002/ijgo.15278

Vancouver

Genazzani AR, Divakar H, Khadilkar SS, Monteleone P, Evangelisti B, Galal AF, et al. Counseling in menopausal women: How to address the benefits and risks of menopause hormone therapy. A FIGO position paper. International Journal of Gynecology & Obstetrics. 2024;164(2):516-530. doi:10.1002/ijgo.15278

BibTeX
@article{Genazzani2024,
  author = {Genazzani, Andrea R and Divakar, Hema and Khadilkar, Suvarna S and Monteleone, Patrizia and Evangelisti, Bernadette and Galal, Ahmed F and Priego, Paola I R and Simoncini, Tommaso and Giannini, Andrea and Goba, Gelila and Benedetto, Chiara},
  title = {Counseling in menopausal women: How to address the benefits and risks of menopause hormone therapy. A FIGO position paper},
  journal = {International Journal of Gynecology & Obstetrics},
  year = {2024},
  volume = {164},
  number = {2},
  pages = {516--530},
  doi = {10.1002/ijgo.15278}
}
Kostenlos starten →